The Safety of an Adenosine A1-Receptor Antagonist, Rolofylline, in Patients with Acute Heart Failure and Renal Impairment

The Role of Intracellular 35-Cyclic Adenosine Monophosphate (cAMP) in Atherosclerosis

(2010) Panayotis Fantidis   Current Vascular Pharmacology

Rolofylline, an Adenosine A1−Receptor Antagonist, in Acute Heart Failure

(2010) Barry M. Massie et al.   NEW ENGLAND JOURNAL OF MEDICINE

Design and Rationale of the PROTECT Study: A Placebo-controlled Randomized Study of the Selective A1 Adenosine Receptor Antagonist Rolofylline for Patients Hospitalized With Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function

(2009) Beth Davison Weatherley et al.   JOURNAL OF CARDIAC FAILURE

Metabolic syndrome, endothelial dysfunction, and risk of cardiovascular events: The Northern Manhattan Study (NOMAS)

(2008) Takeki Suzuki et al.   AMERICAN HEART JOURNAL

The PROTECT Pilot Study: A Randomized, Placebo-Controlled, Dose-Finding Study of the Adenosine A1 Receptor Antagonist Rolofylline in Patients With Acute Heart Failure and Renal Impairment

(2008) Gad Cotter et al.   JOURNAL OF CARDIAC FAILURE

The adenosine kinase hypothesis of epileptogenesis

(2007) Detlev Boison   PROGRESS IN NEUROBIOLOGY